65,437 trials
Ankylosing Spondylitis (AS)
Primary: Percentage of Patients Who Achieved Assessment of Spondyloarthritis International Society (ASAS) 40 Improvement Criteria at Week 12. — 17.5; 25.0; 20.5; 15.0 Percentage…
Aggression · Anger · Posttraumatic Stress Disorder
Primary: Change in Mean Scores on the Conflicts Tactics Scale (CTS) From Baseline to Post-treatment, 3 Month and 6 Month Follow-up. — 0.50; 1.24; 0.22; 1.06 units on a scale…
Ureteral Calculi
Primary: Time in Days From Diagnosis to Stone Passage. — 5; 13 Days
Cardiovascular Disease · Psychological Stress · Stroke
Primary: Perceived Stress — 15.94; 15.50 score on a scale
Type 2 Diabetes Mellitus
Primary: Percentage of Participants With Adverse Events(AEs) and Serious Adverse Event(SAEs) — 52.9; 3.8 percentage of participants
Blood Safety
Primary: Platelet 24-hour Relative Recovery — 43.31; 52.01 Percentage of platelet count
Gastric Stasis
Primary: Percentage of Slow Wave Entrainment — 72; 70; 84; 78 percentage of slow waves entrainment
Healthcare-Associated Pneumonia · Ventilator-Associated Pneumonia · Lung Diseases
Primary: Percentage of Participants With All Cause Mortality in the Intent-to-Treat (ITT) Population - Day 28 — 24.0; 25.3 Percentage of Participants
Obesity
Primary: Adherence to Multivitamin — 32.9; 34.9 percentage of doses taken
Muscle Loss
Primary: Lean Leg Mass — -1.2; -0.9 g
Osteoarthritis
Primary: Percentage of Knees Who Survived at 2 Years Post-operative — 100; 100 Percentage of Knees remaining
Ureteral Patency
Primary: Visual Analog Scale (VAS) — 48; 20; 0; 28 score on a scale
Stress Disorders, Posttraumatic
Primary: Proportion of Maximum Skin Conductance Response (SCR) in Microsiemens (µS) — .0325522; .0245775; -.0181339; .1233174 proportion of max SCR (µS) — p==.66
Chronic Kidney Disease · End Stage Renal Failure on Dialysis · Anemia
Primary: Change in Hemoglobin (Hb) Concentration From Baseline to the Evaluation Period — 4.695; 4.641 gram per liter
Open Angle Glaucoma
Primary: Percentage of Subjects With ≥ 20% Decrease From Baseline to 12 Months Postoperative in IOP Without Use of Ocular Hypotensive Medication — 63.0; 83.3; 73.5 percentage of…